The Association for the Advancement of Medical Instrumentation (AAMI) is reporting that with a new set of Medical Device User Fee Amendments (MDUFA IV) making their way through Congress, the Food and Drug Administration (FDA) is getting a jump-start on a plan to recognize accredited testing laboratories. Under this scheme, the agency would use reports from these laboratories during premarket reviews as evidence of conformity to recognized standards by manufacturers. The agency is asking for feedback on its proposal, which it outlined in a Federal Register notice published May 16. Under the current system, medical device manufacturers can include a “Declaration of Conformity” to identify which voluntary consensus standards they used in their application to meet premarket requirements for their devices. According to the FDA, this system “has not been consistently applied by sponsors in submissions,” causing “challenges for manufacturers and FDA alike.”
To read further from AAMI, CLICK HERE.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
Why Clinical Expertise Is the Cornerstone to Your Most Profitable Business Line
November 14th 2024Perioperative nurses bring vital skills in patient safety, infection control, and quality improvement. They enhance surgical outcomes and support health care systems during complex, high-risk procedures.
Meet Infection Control Today's Editorial Advisory Board Member: Rebecca Leach, MPH, BSN, RN, CIC
September 30th 2024Meet the experts shaping infection prevention: Infection Control Today's Editorial Board members share insights, experiences, and cutting-edge strategies to enhance health care safety and quality. Meet Rebecca Leach, MPH, BSN, RN, CIC.